Cell Line : PK-45H
Cellosaurus Index : CVCL_6748
Cellosaurus ID : PK-45H
CCLE Name
: PK45H_PANCREAS
CTRP2 Name
: PK45H
Cancer Type : pancreas
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| PK-45H | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 17.0000 |
|
| PK-45H | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | AA-COCF3 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| PK-45H | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| PK-45H | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | austocystin D | CTRP2 | 0.0011 | 9.2000 |
|
| PK-45H | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| PK-45H | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| PK-45H | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| PK-45H | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| PK-45H | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| PK-45H | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K13999467 | CTRP2 | 0.0020 | 33.0000 |
|
| PK-45H | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K24690302 | CTRP2 | 0.0020 | 33.0000 |
|
| PK-45H | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| PK-45H | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| PK-45H | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| PK-45H | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K50799972 | CTRP2 | 0.0020 | 17.0000 |
|
| PK-45H | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K55116708 | CTRP2 | 0.0020 | 33.0000 |
|
| PK-45H | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| PK-45H | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| PK-45H | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | BRD4132 | CTRP2 | 0.0097 | 80.0000 |
|
| PK-45H | BRD55319 | CTRP2 | 0.0011 | 18.0000 |
|
| PK-45H | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Carboplatin | CTRP2 | 0.0041 | 66.0000 |
|
| PK-45H | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| PK-45H | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | CD-437 | CTRP2 | 0.0011 | 18.0000 |
|
| PK-45H | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| PK-45H | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| PK-45H | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| PK-45H | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| PK-45H | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| PK-45H | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| PK-45H | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Crizotinib | CTRP2,CCLE | 0.0020 | 33.0000 |
|
| PK-45H | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| PK-45H | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Dabrafenib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| PK-45H | Daporinad | CTRP2 | 0.0001 | 2.0000 |
|
| PK-45H | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Doxorubicin | CTRP2 | 0.0020 | 33.0000 |
|
| PK-45H | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| PK-45H | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Erlotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| PK-45H | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| PK-45H | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| PK-45H | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | FQI-2 | CTRP2 | 0.0010 | 2.1000 |
|
| PK-45H | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| PK-45H | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| PK-45H | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Ibrutinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| PK-45H | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Irinotecan | CCLE | 0.0025 | 8.0000 |
|
| PK-45H | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| PK-45H | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| PK-45H | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| PK-45H | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | KU-0063794 | CTRP2 | 0.0020 | 33.0000 |
|
| PK-45H | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | L-685458 | CTRP2,CCLE | 0.0025 | 18.0000 |
|
| PK-45H | Lapatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| PK-45H | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| PK-45H | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| PK-45H | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | MG-132 | CTRP2 | 0.0006 | 20.0000 |
|
| PK-45H | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | MI-1 | CTRP2 | 0.0020 | 33.0000 |
|
| PK-45H | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | MIRA-1 | CTRP2 | 0.0020 | 4.2000 |
|
| PK-45H | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| PK-45H | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| PK-45H | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| PK-45H | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PK-45H | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| PK-45H | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Nelarabine | CTRP2 | 0.0020 | 33.0000 |
|
| PK-45H | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Nilotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| PK-45H | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| PK-45H | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| PK-45H | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| PK-45H | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Nutlin-3a | CTRP2,CCLE | 0.0025 | 150.0000 |
|
| PK-45H | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| PK-45H | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| PK-45H | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| PK-45H | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Paclitaxel | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| PK-45H | Palbociclib | CCLE | 0.0025 | 8.0000 |
|
| PK-45H | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Panobinostat | CCLE | 0.0025 | 8.0000 |
|
| PK-45H | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Parthenolide | CTRP2 | 0.0020 | 33.0000 |
|
| PK-45H | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | PD0325901 | CCLE | 0.0025 | 8.0000 |
|
| PK-45H | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| PK-45H | Pevonedistat | CTRP2 | 0.0180 | 18.0000 |
|
| PK-45H | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | PF-3758309 | CTRP2 | 0.0020 | 33.0000 |
|
| PK-45H | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| PK-45H | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| PK-45H | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| PK-45H | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| PK-45H | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | PLX-4720 | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| PK-45H | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| PK-45H | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| PK-45H | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| PK-45H | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | RAF265 | CCLE | 0.0025 | 8.0000 |
|
| PK-45H | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| PK-45H | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| PK-45H | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| PK-45H | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| PK-45H | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| PK-45H | Selumetinib | CTRP2,CCLE | 0.0025 | 270.0000 |
|
| PK-45H | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| PK-45H | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 83.0000 |
|
| PK-45H | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| PK-45H | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| PK-45H | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| PK-45H | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| PK-45H | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| PK-45H | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| PK-45H | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| PK-45H | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 83.0000 |
|
| PK-45H | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| PK-45H | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| PK-45H | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| PK-45H | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| PK-45H | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| PK-45H | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| PK-45H | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| PK-45H | Sorafenib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| PK-45H | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | T-5345967 | CTRP2 | 0.0160 | 270.0000 |
|
| PK-45H | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| PK-45H | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| PK-45H | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Tanespimycin | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| PK-45H | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| PK-45H | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Tivozanib | CTRP2 | 0.0004 | 13.0000 |
|
| PK-45H | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| PK-45H | Topotecan | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| PK-45H | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| PK-45H | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Tretinoin | CTRP2 | 0.0041 | 66.0000 |
|
| PK-45H | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| PK-45H | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| PK-45H | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | UNC0321 | CTRP2 | 0.0020 | 33.0000 |
|
| PK-45H | UNC0638 | CTRP2 | 0.0010 | 17.0000 |
|
| PK-45H | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| PK-45H | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| PK-45H | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| PK-45H | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| PK-45H | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| PK-45H | YL54 | CTRP2 | 0.0020 | 33.0000 |
|
| PK-45H | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| PK-45H | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| PK-45H | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC